nitrosamines impurities by m. filancia (ema)
Published 2 years ago • 2.8K plays • Length 17:19Download video MP4
Download video MP3
Similar videos
-
2:52
nitrosamine impurity in pharmaceutical drugs
-
18:11
nitrosamine impurities; what’s the impact on imps
-
2:23
tackling nitrosamine impurities in medicines
-
7:19
nitrosamine impurities || usfda guideline || part-1
-
1:01:17
hunt for n-nitrosamines in medicinal products
-
31:00
nitrosamine impurities in pharmaceuticals; part-1
-
28:15
nitrosamine ndsri impurity basic and limits
-
16:24
medphys - 15.1 - megavoltage electron beams: basic physics and pdd.
-
1:47
nitrosamine impurities | usp
-
10:21
is the less than lifetime (ltl) limit applies to nitrosamines?
-
17:56
update on activities linked to presence of n-nitrosamines in human medicines
-
7:55
ema’s statement on interchangeability of biosimilars
-
41:52
technical tuesday: nitrosamines impurities
-
1:42
ema keeping medicines safe - (multi-language)
-
12:37
which limits apply for nitrosamines in medicinal products?
-
9:13
how to predict the potency category of nitrosamine as per new ema updates
-
2:54
biosimilars - (multi-language)
-
23:53
nitrosamines: where are we now?
-
1:24
ema update on nitrosamine guidelines
-
5:01
nitrosamine impurities, ndsris and setting acceptable intake (ai) limits @toxgyan
-
14:43
interview with naiffer romero at usp on nitrosamine impurities
-
54:41
nitrosamine impurities/ndsris - current regulatory status